
BCE (BCE) Q2 Earnings and Revenues Top Estimates
BCE (BCE) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.46 per share a year ago.
En güncel finans ve ekonomi haberlerini, piyasa gelişmelerini, raporları ve analizleri PipVero’da takip edin.

BCE (BCE) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.46 per share a year ago.

Becton Dickinson (BDX) came out with quarterly earnings of $3.23 per share, beating the Zacks Consensus Estimate of $3.14 per share. This compares to earnings of $3.68 per share a year ago.

Aclaris Therapeutics (ACRS) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to a loss of $0.13 per share a year ago.

AppLovin Corporation delivered a robust quarter with 52.4% revenue growth and an 83.8% adjusted EBITDA margin, yet shares sold off sharply on modest headline misses. APP's balance sheet is strong, with $3B cash, $3.5B debt, and a 29x interest coverage ratio, supporting continued self-funded growth. Opening AXON Ads to self-serve expands TAM, targeting $7B in first-year ad spend from new verticals beyond gaming, including fintech and CTV.

CoreWeave (NASDAQ:CRWV) currently trades at $91.90 against a consensus analyst target of $138.03.

ROSELAND, N.J., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, August 14, 2026, to discuss the company's financial results for the second quarter ended June 30, 2026, as well as the company's corporate progress and other developments.

Toronto, Ontario--(Newsfile Corp. - August 6, 2026) - ATERRA Metals Inc. (CSE: ATC) (OTCQB: CSSCF) ("ATERRA" or the "Company") is pleased to announce that it has commenced preparation of the Company's maiden independent Mineral Resource Estimate ("MRE") for its Totora Cu/Au Project ("Totora" or the "Project"). The maiden MRE will define Totora's initial mineral inventory and establish the technical foundation for future economic studies.

Collaboration supports development of a next-generation AWS-native platform designed to accelerate commercialization, scalability and enterprise adoption

ANI Pharmaceuticals is rated Buy at ~$80, with a 12-month fair value set at $95, as the current valuation undervalues 2027 earnings potential. 2026 results are depressed by upfront gout expansion costs and higher Corticotrophin royalties, but revenue and operating leverage from these investments are expected to materialize in 2027. Most 2026 Cortrophin growth is projected from established indications, not the new gout initiative, which is viewed as a 2027 upside driver.

Advanced Micro Devices (NASDAQ:AMD | AMD Price Prediction) and Marvell Technology (NASDAQ:MRVL) have cleared their most recent earnings, deepening the case for treating them as the market's preferred high beta alternatives to NVIDIA (NASDAQ:NVDA) and Broadcom (NASDAQ:AVGO).

Morgan Advanced Materials plc (MCRUF) Q2 2026 Earnings Call Transcript

Pursuit Attractions and Hospitality, Inc. (PRSU) Q2 2026 Earnings Call Transcript

Hexagon Composites ASA (HXGCF) Q2 2026 Earnings Call Transcript

SAN MATEO, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Freshworks Inc. (NASDAQ: FRSH) today announced that Freshservice, its AI-powered unified service operations platform, has achieved FedRAMP® ‘In-Process' status for Class C (Moderate) certification, signaling significant progress toward full authorization for U.S. federal government agencies. This designation marks a key milestone in Freshworks' plan to deliver modern service management software to federal agencies, and Freshservice is now listed on the FedRAMP Marketplace. Freshworks has engaged Coalfire, a leading provider of FedRAMP compliance assessments, to guide the authorization process.

DALLAS, Aug. 6, 2026 /PRNewswire/ -- NexPoint Real Estate Finance, Inc. ("NREF" or the "Company") (NYSE: NREF) today reported its financial results for the quarter ended June 30, 2026. NREF reported net income attributable to common stockholders of $5.4 million, or $0.29 per diluted share1, for the three months ended June 30, 2026.